Who Just Raised

Solaris Endovascular Inc.

Dallas, TX ยท Biotechnology

Solaris Endovascular Inc. is a biotechnology company based in Dallas, Texas. In a Form D filed with the SEC on October 1, 2026, it reported raising $4,972,500 from 45 investors as part of an offering of up to $10,000,000. The first sale in the offering took place on September 5, 2025.

Website
solarisendovascular.com
Amount raised
$4,972,500
Offering size
$10,000,000
Investors so far
45
Minimum investment
$2,500
First sale
September 5, 2025
Securities offered
Equity, Debt, Options or warrants
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Dallas, Texas
Incorporated
Delaware, 2024
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $4,972,500 $10,000,000 45 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in Texas

Company Location Sector Raised Target Filed
FibroBiologics, Inc. Houston, TX Health Care $1.2M $1.2M
Lucier Pharmaceuticals Inc. Bryan, TX Health Care โ€” $2M
Surgical Caregivers of Fort Worth, LLC Fort Worth, TX Health Care โ€” $498K
TMF1 Akido, LLC Houston, TX Health Care โ€” $1M
OncoNano Medicine, Inc. Dallas, TX Health Care $10.1M $15M
Pressio, Inc. San Antonio, TX Health Care $544K $6M